Pitavastatin-Incorporated Nanoparticles for Chronic Limb Threatening Ischemia: A Phase I/IIa Clinical Trial
出版年份 2021 全文链接
标题
Pitavastatin-Incorporated Nanoparticles for Chronic Limb Threatening Ischemia: A Phase I/IIa Clinical Trial
作者
关键词
-
出版物
Journal of Atherosclerosis and Thrombosis
Volume 29, Issue 5, Pages 731-746
出版商
Japan Atherosclerosis Society
发表日期
2021-04-28
DOI
10.5551/jat.58941
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Safety, Tolerability, and Pharmacokinetics of NK-104-NP
- (2018) Kaku Nakano et al. International Heart Journal
- Nanoparticle-Mediated Targeting of Pitavastatin to Small Pulmonary Arteries and Leukocytes by Intravenous Administration Attenuates the Progression of Monocrotaline-Induced Established Pulmonary Arterial Hypertension in Rats
- (2018) Kenzo Ichimura et al. International Heart Journal
- Nanoparticle-Mediated Delivery of Pitavastatin to Monocytes/Macrophages Inhibits Left Ventricular Remodeling After Acute Myocardial Infarction by Inhibiting Monocyte-Mediated Inflammation
- (2017) Yajing Mao et al. International Heart Journal
- Anti-inflammatory Nanoparticle for Prevention of Atherosclerotic Vascular Diseases
- (2016) Jun-ichiro Koga et al. Journal of Atherosclerosis and Thrombosis
- A Translational Study of a New Therapeutic Approach for Acute Myocardial Infarction: Nanoparticle-Mediated Delivery of Pitavastatin into Reperfused Myocardium Reduces Ischemia-Reperfusion Injury in a Preclinical Porcine Model
- (2016) Kenzo Ichimura et al. PLoS One
- A New Therapeutic Modality for Acute Myocardial Infarction: Nanoparticle-Mediated Delivery of Pitavastatin Induces Cardioprotection from Ischemia-Reperfusion Injury via Activation of PI3K/Akt Pathway and Anti-Inflammation in a Rat Model
- (2015) Kazuhiro Nagaoka et al. PLoS One
- Amelioration of Ischemic Mitochondrial Injury and Bax-Dependent Outer Membrane Permeabilization by Mdivi-1
- (2014) Yan-Xin Zhao et al. CNS Neuroscience & Therapeutics
- Nanoparticle-Mediated Delivery of Pitavastatin Inhibits Atherosclerotic Plaque Destabilization/Rupture in Mice by Regulating the Recruitment of Inflammatory Monocytes
- (2013) Shunsuke Katsuki et al. CIRCULATION
- Both autologous bone marrow mononuclear cell and peripheral blood progenitor cell therapies similarly improve ischaemia in patients with diabetic foot in comparison with control treatment
- (2013) M. Dubsky et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Pitavastatin-Incorporated Nanoparticle-Eluting Stents Attenuate In-Stent Stenosis without Delayed Endothelial Healing Effects in a Porcine Coronary Artery Model
- (2012) Noriaki Tsukie et al. Journal of Atherosclerosis and Thrombosis
- Nanoparticle-Mediated Delivery of Pitavastatin Into Lungs Ameliorates the Development and Induces Regression of Monocrotaline-Induced Pulmonary Artery Hypertension
- (2011) Ling Chen et al. HYPERTENSION
- Effect of fibroblast growth factor NV1FGF on amputation and death: a randomised placebo-controlled trial of gene therapy in critical limb ischaemia
- (2011) Jill Belch et al. LANCET
- A novel nucleic acid analogue shows strong angiogenic activity
- (2010) Ikuko Tsukamoto et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Nanoparticle-mediated endothelial cell-selective delivery of pitavastatin induces functional collateral arteries (therapeutic arteriogenesis) in a rabbit model of chronic hind limb ischemia
- (2010) Shinichiro Oda et al. JOURNAL OF VASCULAR SURGERY
- Therapeutic Neovascularization by Nanotechnology-Mediated Cell-Selective Delivery of Pitavastatin Into the Vascular Endothelium
- (2009) Mitsuki Kubo et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Therapeutic Angiogenesis With Intramuscular NV1FGF Improves Amputation-free Survival in Patients With Critical Limb Ischemia
- (2008) Sigrid Nikol et al. MOLECULAR THERAPY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now